Wang, Rong
Luo, Haoyun
Ye, Yijing
Xiang, Ling
Chen, Qijiu
Funding for this research was provided by:
National Natural Science Foundation of China (81860526)
China Postdoctoral Science Foundation (2021M703683)
Article History
Received: 8 March 2024
Accepted: 9 October 2024
First Online: 17 October 2024
Declarations
:
: The study is in line with the Helsinki Declaration. The PLCO Cancer Screening Trial design was approved by the Institutional Review Board of the NCI and each of the screening centers. Participants provided written informed consent prior to participation in this study.
: Not applicable.
: The authors declare no competing interests.